Stages of breast cancer

The stage of your breast cancer is a key factor in determining the type of treatment you will receive. At Penn Medicine, our breast cancer pathologists and radiologists use their expertise to accurately stage breast cancer. The detailed information they provide ensures that you get the most appropriate treatment based on your diagnosis.

How is breast cancer staged and graded?

After a breast cancer diagnosis, doctors assign a cancer stage based on the cancer’s location, tumor size, and whether it has spread. Staging directs breast cancer treatment and may be a qualifying factor for some clinical trials.

Breast cancer is staged using advanced breast imaging, breast biopsy, and other diagnostic tests. How we stage cancer depends on whether you have had breast cancer surgery. There are two types of staging for breast cancer:

  • Clinical staging: We stage cancer prior to surgery. The stage is based on a physical exam, nonsurgical biopsy, and breast imaging. 
  • Pathologic staging: We study tissue removed during breast cancer surgery. For advanced cancer, we also use information obtained from a sentinel lymph node biopsy. Whenever possible, we use pathologic staging, because it provides the most accurate picture of breast cancer.

What is the TNM system for staging breast cancer?

The TNM system for cancer staging refers to an international standard for classifying the malignancy of a tumor based on a list of factors involving the tumor (T), node (N), and metastases (M). The criteria used includes:

  • Size of the tumor (T): How large is the area of cancer?
  • Spread to lymph nodes (N): Has the cancer spread to nearby lymph nodes?
  • Metastasis to distant sites (M): Has the cancer spread to other areas of the body?
  • Hormone receptor status: Is it indicative of hormone-positive breast cancer?
  • HER2 (human epidermal growth factor receptor 2) status: Is the cancer HER2-positive?
  • Grade of the cancer (G): How closely do cancer cells resemble normal cells?

We use this information to determine the most appropriate disease stage. Every breast cancer is unique, making staging a complex process. Your breast cancer team can answer any questions about staging.

National Cancer Institute Designated Comprehensive Cancer Center badge on top of shot of hospital

Rated “exceptional” by The National Cancer Institute

Penn Medicine’s Abramson Cancer Center is a world leader in cancer research, patient care, and education. Our status as a national leader in cancer care is reflected in our continuous designation as a Comprehensive Cancer Center by the National Cancer Institute (NCI) since 1973, one of 7 such centers in the United States. The ACC is also a member of the National Comprehensive Cancer Network, one of a select few cancer centers in the U.S., that are working to promote equitable access to high-quality, advanced cancer care.

Schedule an appointment

We can help you schedule an appointment or you can search our directory of specialists.